Pepcid AC proposed switch in Canada gets pharmacy-sale recommendation.
This article was originally published in The Tan Sheet
Executive Summary
PEPCID AC SWITCH IN CANADA PROPOSED FOR PHARMACY-SALE STATUS by the newly formed National Drug Scheduling Advisory Committee (NDSAC) on Aug. 30. Once approved by the Canadian government for nonprescription sale, the heartburn remedy will be marketed by Merck Frosst.